Abstract
Factors influencing brain uptake of benzodiazepine derivatives were evaluated in adult Sprague Dawley rats (n=8–10 per drug). Animals received single intraperitoneal doses of alprazolam, triazolam, lorazepam, flunitrazepam, diazepam, midazolam, desmethyldiazepam, or clobazam. Concentrations of each drug (and metabolites) in whole brain and serum 1 h after dosage were determined by gas chromatography. Serum free fraction was measured by equilibrium dialysis. In vitro binding affinity (apparentK i) of each compound was estimated based on displacement of tritiated flunitrazepam in washed membrane preparations from rat cerebral cortex. Lipid solubility of each benzodiazepine was estimated using the reverse-phase liquid chromatographic (HPLC) retention index at physiologic pH. There was no significant relation between brain:total serum concentration ratio and either HPLC retention (r=0.18) or bindingK i (r=−0.34). Correction of uptake ratios for free as opposed to total serum concentration yielded a highly significant correlation with HPLC retention (r=0.78,P<0.005). However, even the corrected ratio was not correlated with bindingK i (r=−0.22). Thus a benzodiazepine's capacity to diffuse from systemic blood into brain tissue is much more closely associated with the physico-chemical property of lipid solubility than with specific affinity. Unbound rather than total serum or plasma concentration most accurately reflects the quantity of drug available for diffusion.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abernethy DR, Greenblatt DJ, Divoll M (1983) Prolonged accumulation of diazepam in obesity. J Clin Pharmacol 23:369–376
Arendt RM, Greenblatt DJ, Jong RH, Bonin JD, Abernethy DR, Ehrenberg BL, Giles HG, Sellers EM, Shader RI (1983) In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action, and peripheral distribution. J Pharmacol Exp Ther 227:95–106
Arendt RM, Greenblatt DJ, Garland WA (1984) Quantitation by gas chromatography of the 1- and 4-hydroxy metabolites of midazolam in human plasma. Pharmacology 29:158–164
Borea PA, Bonora A (1983) Brain receptor binding and lipophilic character of benzodiazepines. Biochem Pharmacol 32:603–607
Eatman FB, Colburn WA, Boxenbaum HG, Posmanter HN, Weinfeld RE, Ronfeld R, Weissman L, Moore JD, Gibaldi M, Kaplan SA (1977) Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects. J Pharmacokinet Biopharm 5:481–494
Greenblatt DJ (1980) Electron-capture GLC determination of clobazam and desmethylclobazam in plasma. J Pharm Sci 69:1351:1352
Greenblatt DJ, Shader RI (1985) Clinical pharmacokinetics of the benzodiazepines. In: Smith DE, Wesson DR (eds) The benzodiazepines: current standards for medical practice. M.T.P. Press, Lancaster, UK, pp 43–58
Greenblatt DJ, Franke K, Shader RI (1978) Analysis of lorazepam and its glucuronide metabolite by electron-capture gas-liquid chromatography: use in pharmacokinetic studies of lorazepam. J Chromatogr 146:311–320
Greenblatt DJ, Ochs HR, Lloyd BL (1980) Entry of diazepam and its major metabolite into cerebrospinal fluid. Psychopharmacology 70:89–93
Greenblatt DJ, Laughren TP, Allen MD, Harmatz JS, Shader RI (1981a) Plasma diazepam and desmethyldiazepam concentrations during long-term diazepam therapy. Br J Clin Pharmacol 11:35–40
Greenblatt DJ, Divoll M, Moschitto LJ, Shader RI (1981b) Electron-capture gas chromatographic analysis of the triazolobenzodiazepines alprazolam and triazolam. J Chromatogr 225:202–207
Greenblatt DJ, Shader RI, Abernethy DR, Ochs HR, Divoll M, Sellers EM (1982a) Benzodiazepines and the challenge of pharmacokinetic taxonomy. In: Usdin E, Skolnick P, Tallman JF, Greenblatt D, Paul SM (eds) Pharmacology of benzodiazepines. MacMillan, London, pp 257–269
Greenblatt DJ, Sellers EM, Koch-Weser J (1982b) Importance of protein binding for the interpretation of serum or plasma drug concentrations. J Clin Pharmacol 22:259–263
Greenblatt DJ, Ochs HR, Locniskar A, Lauven PM (1982c) Automated electron-capture gas chromatographic analysis of flunitrazepam in plasma. Pharmacology 24:82–87
Greenblatt DJ, Shader RI, Abernethy DR (1983a) Current status of benzodiazepines. N Engl J Med 309:354–358, 410–416
Greenblatt DJ, Divoll M, Abernethy DR, Ochs HR, Shader RI (1983b) Benzodiazepine kinetics: implications for therapeutics and pharmacogeriatrics. Drug Metab Rev 14:251–292
Greenblatt DJ, Arendt RM, Abernethy DR, Giles HG, Sellers EM, Shader RI (1983c) In vitro quantitation of benzodiazepine lipophilicity: relation to in vivo distribution. Br J Anaesth 55:985–989
Greenblatt DJ, Divoll M, Shader RI (1983d) Automated gas chromatographic determination of plasma alprazolam concentrations. J Clin Psychopharmacol 3:366–368
Greenblatt DJ, Divoll M, Puri SK, Ho I, Zinny MA, Shader RI (1983e) Reduced single-dose clearance of clobazam in elderly men predicts increased multiple-dose accumulation. Clin Pharmacokinet 8:83–94
Greenblatt DJ, Abernethy DR, Morse DS, Shader RI, Harmatz JS (1984) Clinical importance of the interaction of diazepam and cimetidine. N Engl J Med 310:1639–1643
Guentert TW (1984) Pharmacokinetics of benzodiazepines and of their metabolites. Prog Drug Metab 8:241–386
Klotz U, Kangas L, Kanto J (1980) Clinical pharmacokinetics of benzodiazepines. Prog Pharmacol 3 (No. 3):1–72
McPherson GA (1983) A practical computer-based approach to the analysis of radioligand binding experiments. Comput Progr Biomed 17:107–114
Miller LG, Greenblatt DJ, Shader RI (1987a) Benzodiazepine receptor binding: influence of physiologic and pharmacologic factors. Biopharm Drug Dispos 8:103–114
Miller LG, Greenblatt DJ, Paul SM, Shader RI (1987b) Benzodiazepine receptor occupancy in vivo: correlation with brain concentrations and pharmacodynamic actions. J Pharmacol Exp Ther 240:516–522
Moschitto LJ, Greenblatt DJ (1983) Concentration-independent plasma protein binding of benzodiazepines. J Pharm Pharmacol 35:179–180
Müller WE (1981) The benzodiazepine receptor: an update. Pharmacology 22:153–161
Ochs HR, Greenblatt DJ, Eckardt B, Harmatz JS, Shader RI (1983) Repeated diazepam dosing in cirrhotic patients: cumulation and sedation. Clin Pharmacol Ther 33:471–476
Ochs HR, Greenblatt DJ, Lüttkenhorst M, Verburg-Ochs B (1984) Single and multiple dose kinetics of clobazam, and clinical effects during multiple dosage. Eur J Clin Pharmacol 26:499–503
Reves JG, Fragen RH, Vinik HR, Greenblatt DJ (1985) Midazolam: pharmacology and uses. Anesthesiology 62:310–324
Scavone JM, Friedman H, Greenblatt DJ, Shader RI (1987) Effect of age, body composition, and lipid solubility on benzodiazepine tissue distribution in rats. Arzneimittelforschung 37:2–6
Sellers EM, Naranjo CA, Khouw V, Greenblatt DJ (1982) Binding of benzodiazepines to plasma proteins. In: Usdin E, Skolnick P, Tallman JF, Greenblatt D, Paul SM (eds) Pharmacology of benzodiazepines. MacMillan, London, pp 271–284
Sieghart W, Eichinger A, Riederer P, Jellinger K (1985) Comparison of benzodiazepine receptor binding in membranes from human or rat brain. Neuropharmacology 24:751–759
Skolnick P, Paul SM (1982) Benzodiazepine receptors in the central nervous system. Int Rev Neurobiol 23:103–140
Tallman JF, Paul SM, Skolnick P, Gallager DW (1980) Receptors for the age of anxiety: pharmacology of the benzodiazepines. Science 207:274–281
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arendt, R.M., Greenblatt, D.J., Liebisch, D.C. et al. Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity. Psychopharmacology 93, 72–76 (1987). https://doi.org/10.1007/BF02439589
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02439589